Arijeet Kaushik Gattu, M.B.,B.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Serpins | 6 | 2014 | 247 | 1.420 |
Why?
|
| Nerve Growth Factors | 6 | 2014 | 576 | 1.290 |
Why?
|
| Eye Proteins | 6 | 2014 | 646 | 1.230 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2014 | 452 | 0.410 |
Why?
|
| Insulin | 6 | 2023 | 6583 | 0.390 |
Why?
|
| Adipogenesis | 1 | 2013 | 359 | 0.370 |
Why?
|
| Hepatocytes | 2 | 2014 | 1210 | 0.340 |
Why?
|
| Interleukin-1beta | 1 | 2014 | 972 | 0.320 |
Why?
|
| Adiposity | 2 | 2019 | 1807 | 0.310 |
Why?
|
| Liver | 7 | 2019 | 7472 | 0.310 |
Why?
|
| Metagenome | 1 | 2011 | 418 | 0.310 |
Why?
|
| Insulin Resistance | 4 | 2015 | 3863 | 0.300 |
Why?
|
| Gastrointestinal Tract | 1 | 2011 | 814 | 0.250 |
Why?
|
| Palmitic Acid | 2 | 2015 | 154 | 0.230 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2013 | 1628 | 0.220 |
Why?
|
| Adipocytes | 3 | 2014 | 1182 | 0.210 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (GTP) | 2 | 2019 | 38 | 0.200 |
Why?
|
| Obesity, Morbid | 1 | 2012 | 1213 | 0.200 |
Why?
|
| Receptor, Insulin | 2 | 2023 | 846 | 0.190 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2023 | 390 | 0.190 |
Why?
|
| Bone Density | 1 | 2013 | 3468 | 0.180 |
Why?
|
| Liver Glycogen | 1 | 2019 | 34 | 0.170 |
Why?
|
| Signal Transduction | 3 | 2023 | 23404 | 0.160 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2019 | 433 | 0.140 |
Why?
|
| Hypogonadism | 1 | 2022 | 798 | 0.140 |
Why?
|
| Triglycerides | 3 | 2015 | 2453 | 0.130 |
Why?
|
| Ethanol | 2 | 2014 | 1342 | 0.130 |
Why?
|
| Nuclear Receptor Coactivator 1 | 1 | 2014 | 42 | 0.130 |
Why?
|
| Testosterone | 2 | 2022 | 2411 | 0.130 |
Why?
|
| Androgens | 1 | 2022 | 1279 | 0.120 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 1 | 2014 | 57 | 0.120 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 4 | 1 | 2014 | 73 | 0.120 |
Why?
|
| Succinic Acid | 1 | 2014 | 83 | 0.110 |
Why?
|
| Microspheres | 1 | 2014 | 777 | 0.100 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2019 | 2916 | 0.090 |
Why?
|
| Glucose Tolerance Test | 1 | 2014 | 1150 | 0.090 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2014 | 955 | 0.090 |
Why?
|
| PPAR gamma | 1 | 2013 | 493 | 0.090 |
Why?
|
| Glucose Intolerance | 1 | 2014 | 577 | 0.090 |
Why?
|
| Thrombospondin 1 | 1 | 2011 | 250 | 0.090 |
Why?
|
| Mice, Knockout | 3 | 2014 | 14556 | 0.090 |
Why?
|
| Cells, Cultured | 4 | 2013 | 19227 | 0.090 |
Why?
|
| Wnt Proteins | 1 | 2013 | 721 | 0.080 |
Why?
|
| DNA, Bacterial | 1 | 2014 | 1467 | 0.080 |
Why?
|
| Permeability | 1 | 2011 | 738 | 0.080 |
Why?
|
| Muscle, Skeletal | 2 | 2014 | 4935 | 0.080 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2007 | 98 | 0.080 |
Why?
|
| Osteoblasts | 1 | 2013 | 1165 | 0.080 |
Why?
|
| Adiponectin | 1 | 2013 | 1100 | 0.070 |
Why?
|
| Enzyme Inhibitors | 2 | 2015 | 3800 | 0.070 |
Why?
|
| Lipopolysaccharides | 1 | 2014 | 2216 | 0.070 |
Why?
|
| Lipase | 1 | 2007 | 315 | 0.070 |
Why?
|
| Disease | 1 | 2011 | 681 | 0.070 |
Why?
|
| Metabolomics | 1 | 2014 | 1483 | 0.060 |
Why?
|
| RNA Interference | 1 | 2014 | 2890 | 0.060 |
Why?
|
| Intestines | 1 | 2014 | 1924 | 0.060 |
Why?
|
| Animals | 11 | 2023 | 168788 | 0.060 |
Why?
|
| Pancreas | 1 | 2011 | 1686 | 0.060 |
Why?
|
| Mice | 7 | 2023 | 81178 | 0.060 |
Why?
|
| Homeostasis | 2 | 2011 | 3339 | 0.050 |
Why?
|
| Penile Erection | 1 | 2022 | 97 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 3 | 2019 | 21824 | 0.050 |
Why?
|
| Glucose | 1 | 2014 | 4396 | 0.050 |
Why?
|
| Leucine | 1 | 2023 | 561 | 0.050 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2023 | 563 | 0.050 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2022 | 548 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2022 | 11074 | 0.040 |
Why?
|
| Cell Line | 1 | 2013 | 15999 | 0.040 |
Why?
|
| Glucokinase | 1 | 2019 | 103 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2012 | 6259 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2019 | 11732 | 0.040 |
Why?
|
| Lipogenesis | 1 | 2019 | 212 | 0.040 |
Why?
|
| Hormone Replacement Therapy | 1 | 2022 | 744 | 0.040 |
Why?
|
| Male | 9 | 2022 | 350027 | 0.030 |
Why?
|
| Phenotype | 1 | 2014 | 16365 | 0.030 |
Why?
|
| Adipose Tissue, White | 1 | 2019 | 346 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2019 | 8302 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 12075 | 0.030 |
Why?
|
| Humans | 11 | 2023 | 744220 | 0.030 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2023 | 2014 | 0.030 |
Why?
|
| Prostaglandin D2 | 1 | 2014 | 122 | 0.030 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2014 | 109 | 0.030 |
Why?
|
| Bacterial Translocation | 1 | 2014 | 73 | 0.030 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2014 | 250 | 0.030 |
Why?
|
| Inflammation | 1 | 2014 | 10634 | 0.030 |
Why?
|
| Rats | 3 | 2019 | 24273 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2023 | 2440 | 0.030 |
Why?
|
| Lipocalins | 1 | 2014 | 170 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2023 | 2938 | 0.030 |
Why?
|
| Acute-Phase Proteins | 1 | 2014 | 262 | 0.030 |
Why?
|
| Fatty Liver | 2 | 2008 | 729 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2014 | 474 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2023 | 8437 | 0.020 |
Why?
|
| Chemokine CCL2 | 1 | 2014 | 617 | 0.020 |
Why?
|
| Obesity | 1 | 2014 | 12742 | 0.020 |
Why?
|
| Biological Transport | 1 | 2014 | 2120 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2014 | 1213 | 0.020 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2011 | 625 | 0.020 |
Why?
|
| Gelatinases | 1 | 2008 | 94 | 0.020 |
Why?
|
| Collagen Type I | 1 | 2011 | 592 | 0.020 |
Why?
|
| Pyrones | 1 | 2007 | 36 | 0.020 |
Why?
|
| Hepatic Stellate Cells | 1 | 2008 | 109 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 2014 | 996 | 0.020 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2011 | 644 | 0.020 |
Why?
|
| Naphthalenes | 1 | 2007 | 194 | 0.020 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2007 | 215 | 0.020 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2008 | 472 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2008 | 638 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2008 | 1903 | 0.020 |
Why?
|
| Fibrosis | 1 | 2011 | 2029 | 0.020 |
Why?
|
| Pancreatitis | 1 | 2011 | 1091 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2014 | 3201 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2011 | 1741 | 0.010 |
Why?
|
| Intestinal Mucosa | 1 | 2014 | 3036 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2014 | 4419 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2014 | 3278 | 0.010 |
Why?
|
| Middle Aged | 2 | 2014 | 213367 | 0.010 |
Why?
|
| Adult | 2 | 2014 | 214035 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2022 | 23337 | 0.010 |
Why?
|
| Sex Factors | 1 | 2014 | 10396 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2008 | 1888 | 0.010 |
Why?
|
| Female | 3 | 2014 | 380197 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 6612 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2014 | 21752 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2011 | 13036 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2014 | 12207 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 16687 | 0.010 |
Why?
|
| Aged | 1 | 2022 | 163253 | 0.010 |
Why?
|